Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Express Scripts
Federal Trade Commission
Chubb
Healthtrust
Johnson and Johnson
Cantor Fitzgerald
McKinsey
Farmers Insurance
Covington

Generated: August 22, 2017

DrugPatentWatch Database Preview

TREXALL Drug Profile

« Back to Dashboard

What is the patent landscape for Trexall, and what generic Trexall alternatives are available?

Trexall is a drug marketed by Barr and is included in one NDA.

The generic ingredient in TREXALL is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.

Summary for Tradename: TREXALL

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list90
Clinical Trials: see list23
Patent Applications: see list9,481
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TREXALL at DailyMed

Pharmacology for Tradename: TREXALL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr
TREXALL
methotrexate sodium
TABLET;ORAL040385-001Mar 21, 2001RXNoNo► Subscribe► Subscribe► Subscribe
Barr
TREXALL
methotrexate sodium
TABLET;ORAL040385-004Mar 21, 2001RXNoYes► Subscribe► Subscribe► Subscribe
Barr
TREXALL
methotrexate sodium
TABLET;ORAL040385-002Mar 21, 2001RXNoNo► Subscribe► Subscribe► Subscribe
Barr
TREXALL
methotrexate sodium
TABLET;ORAL040385-003Mar 21, 2001RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
UBS
Healthtrust
Fish and Richardson
Chubb
QuintilesIMS
Colorcon
Boehringer Ingelheim
Deloitte
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot